Literature DB >> 2615934

Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction.

J J Downes1, A C Roberts, B J Sahakian, J L Evenden, R G Morris, T W Robbins.   

Abstract

Groups of patients with Parkinson's disease, either medicated, or unmedicated and early in the course, together with age- and IQ-matched control subjects were tested in two paradigms measuring different aspects of selective attention. The first set of tests compared visual discrimination learning following intra- and extra-dimensional shifts, using a "total change" design in which each shift was made in the presence of novel exemplars of the compound stimuli used as discriminanda. The second test consisted of a visual search task in which the number of alternatives was varied. The results of the first experiment showed a selective deficit in both groups of Parkinsonian subjects in their ability to perform an extra-dimensional shift. In the visual search task, the patients were less accurate, but responded with equivalent choice reaction times to those of controls. The results are discussed in terms of the nature of the attentional dysfunction that occurs in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2615934     DOI: 10.1016/0028-3932(89)90128-0

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  97 in total

1.  Role of the dorsomedial striatum in behavioral flexibility for response and visual cue discrimination learning.

Authors:  Michael E Ragozzino; Katharine E Ragozzino; Sheri J Y Mizumori; Raymond P Kesner
Journal:  Behav Neurosci       Date:  2002-02       Impact factor: 1.912

2.  Aged rats are impaired on an attentional set-shifting task sensitive to medial frontal cortex damage in young rats.

Authors:  Morgan D Barense; Matthew T Fox; Mark G Baxter
Journal:  Learn Mem       Date:  2002 Jul-Aug       Impact factor: 2.460

Review 3.  Neurocognitive elements of antisocial behavior: Relevance of an orbitofrontal cortex account.

Authors:  Jean R Séguin
Journal:  Brain Cogn       Date:  2004-06       Impact factor: 2.310

4.  Deficient maturation of aspects of attention and executive functions in early onset schizophrenia.

Authors:  Jens Richardt M Jepsen; Birgitte Fagerlund; Anne Katrine Pagsberg; Anne Marie R Christensen; Merete Nordentoft; Erik L Mortensen
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-08-01       Impact factor: 4.785

5.  Computational Models Inform Clinical Science and Assessment: An Application to Category Learning in Striatal-Damaged Patients.

Authors:  W Todd Maddox; J Vincent Filoteo; Dagmar Zeithamova
Journal:  J Math Psychol       Date:  2010-02-01       Impact factor: 2.223

Review 6.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

7.  Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB.

Authors:  B J Sahakian; A M Owen; N J Morant; S A Eagger; S Boddington; L Crayton; H A Crockford; M Crooks; K Hill; R Levy
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

9.  Diazepam produces disinhibitory cognitive effects in male volunteers.

Authors:  J B Deakin; M R F Aitken; J H Dowson; T W Robbins; B J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2003-12-19       Impact factor: 4.530

10.  Development of cognitive control and executive functions from 4 to 13 years: evidence from manipulations of memory, inhibition, and task switching.

Authors:  Matthew C Davidson; Dima Amso; Loren Cruess Anderson; Adele Diamond
Journal:  Neuropsychologia       Date:  2006-03-31       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.